|
|
Volumn 10, Issue 5, 2011, Pages 323-324
|
|
Bridging the drug-diagnostic divide
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
INTERLEUKIN 13;
LEBRIKIZUMAB;
OXALIPLATIN;
PLX 4032;
TAXANE DERIVATIVE;
ASTHMA;
DIAGNOSTIC TEST;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG MARKETING;
DRUG PROGRAM;
DRUG RESEARCH;
HUMAN;
LUNG CANCER;
MELANOMA;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
SHORT SURVEY;
COOPERATIVE BEHAVIOR;
DIAGNOSTIC TECHNIQUES AND PROCEDURES;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
INDIVIDUALIZED MEDICINE;
INDUSTRY;
|
|
EID: 79955640888
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3440 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (0)
|
